Frontline COVID-19
Critical Care Alliance

MATH+ Early Intervention

Treatment Protocol
Is Saving Lives

The world is desperate to find a treatment that will save the lives of COVID-19 patients who come into the emergency room or hospital with low oxygen levels or are struggling to breathe. Started in March, 2020, as a ‹Working Group› of eight leading physicians, including five clinicians with over 200 years of combined experience in Critical Care and Emergency Medicine, who designed the MATH+ Hospital Treatment Protocol for COVID-19, our team, to date, is having remarkable success using MATH+ to treat patients in hospitals that permit its use. We are in the process of gathering patient data to scientifically prove that point. We changed our name to FLCCC Alliance because many other physicians are joining us in using most, if not all, of the MATH+ treatment medicines in their hospitals, and we hope to add their names here soon.

The administration of intravenous corticosteroids and ascorbic acid, starting in the emergency room and continued around the clock while the patient is in the hospital, greatly reduces the mortality rate of this disease and the need for mechanical ventilation. Furthermore, the inflammation caused by COVID-19 appears to cause high rates of blood clotting in multiple organs, necessitating the use of blood thinners.

Our core team of clinician scholars have not only the highest level of bedside expertise, but also have published more than 1,500 articles in peer-reviewed journals in the areas of corticosteroid and intravenous ascorbic acid use in critical illness, sepsis, and acute respiratory distress syndrome (ARDS). We discuss why the MATH+ protocol works against COVID-19 in the video below.

The components of MATH+ are off-patent, inexpensive, and globally available. So if we know that  MATH+ works, produces few side effects, and saves lives that would otherwise be lost, why isn’t it being used throughout the world? CLICK HERE TO FIND OUT.

Front Line Covid-19 Critical Care Alliance – Founders

G. Umberto Meduri, M.D.

  • Professor of Medicine
  • Division of Pulmonary, Critical Care & Sleep Medicine
  • Univ. of Tennessee Health Science Center Memphis, Tennessee
  • Memphis V.A. Medical Center

Paul E. Marik, M.D., FCCM, FCCP

  • Endowed Professor of Medicine
  • Chief, Div. of Pulmonary & Critical Care Medicine
  • Eastern Virginia Medical School Norfolk, Virginia

Joseph Varon, M.D., FCCP, FCCM

  • Professor of Acute & Continuing Care
  • The University of Texas Health Science Center
  • Chief of Staff & Chief of Critical Care
  • United Memorial Medical Center, Houston, Texas

Scott Mitchell, MRCS

  • Associate Specialist
  • Emergency Department
  • Princess Elizabeth Hospital
  • States of Guernsey

Howard Kornfeld, M.D.

  • Board Certified: Emergency Med., Pain Med., Addiction Med.
  • President, Pharmacology Policy Institute
  • Clinical Faculty, Pain Fellowship Program,
    Univ. of California, San Francisco (UCSF) School of Medicine
  • Founder & Medical Director, Recovery Without Walls
    Mill Valley, California

Pierre Kory, M.D., M.P.A.

  • Medical Dir., Trauma & Life Support Center
  • Critical Care Service Chief
  • Associate Professor of Medicine Univ. of Wisconsin School of Medicine & Public Health

Jose Iglesias, D.O.

  • Assoc. Prof., Hackensack Meridian School of Medicine at Seton Hall
  • Dept. of Nephrology & Critical Care / Community Medical Center
  • Dept. of Nephrology, Jersey Shore University Medical Center
  • Neptune, New Jersey

Eivind H. Vinjevoll, M.D.

  • Senior Consultant Anesthesiologist
  • Intensive Care, Emergency Medicine, Anesthesia
  • Volda, Norway

Keith Berkowitz, M.D., M.B.A.

  • Medical Director, Center for Balanced Health
  • Voluntary Attending Physician, Lenox Hill Hosp. New York,
  • New York

Fred Wagshul, M.D.

  • Pulmonologist & Med. Dir., Lung Center of America
  • Clinical Instructor, Wright State University School of Medicine,
  • Dayton, Ohio
You Can Help Make A Difference.

Your Donation could help save a life!

The funds collected are solely for the purpose of getting word of this effective treatment protocol out to physicians and hospitals around the world. As such, some will support scientific studies needed to validate the successes our doctors have observed in their hospitals. Most goes toward the work needed to update this website and our social media outreach with the latest information needed by medical professionals worldwide, who can use it to save lives. Nothing goes to the doctors on the FLCCC team; in fact, they are donors. Please join us.